Spyre Therapeutics, Inc. (SYRE)

43.88 +0.43 (+0.99%) USD  |  NASDAQ  |  Feb 25, 16:00
43.88 0.00 (0.00%) Pre-Market: 08:32
More

Spyre Therapeutics EPS Basic from Tax Loss Carryforward (Quarterly)

EPS Basic from Tax Loss Carryforward (Quarterly) Chart

View EPS Basic from Tax Loss Carryforward (Quarterly) for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Basic from Tax Loss Carryforward (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Basic from Tax Loss Carryforward (Quarterly) Range, Past 5 Years

View EPS Basic from Tax Loss Carryforward (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Basic from Tax Loss Carryforward (Quarterly) Benchmarks

View EPS Basic from Tax Loss Carryforward (Quarterly) Benchmarks
Start Trial
PTC Therapeutics, Inc. --
Tandem Diabetes Care, Inc. --
ACADIA Pharmaceuticals, Inc. --
Alnylam Pharmaceuticals, Inc. --
Savara, Inc. --